Skip to content

K-Stock Briefing

https://kstockbriefing.com

  • About Us
  • Weekly News
  • IR Room
  • RESEARCH
    • Semiconductors
  • Disclosures
    • Semiconductors
    • Energy
    • Bio & Healthcare
    • Defense
    • Shipbuilding
    • Automotive
  • Toggle search form
  • [Disclosure] Hanwha Aerospace (012450) – Supply Contract / 2024-05-09 Disclosures
  • [Disclosure] Hana Micron (067310) – Investor Relations (IR) Meeting / 2026-03-10 Semiconductors
  • [Disclosure] Hanmi Semiconductor (042700) – (Correction) Decision on Acquisition of Other Corporation’s Shares and Equity Securities / 2026-06-15 Semiconductors
  • [Disclosure] ALTEOGEN (196170) – Application for Domestic Marketing Authorization for EYZANFY (ALT-L9) / 2024-09-12 Disclosures
  • [Disclosure] Hanwha Ocean (042660) – Other Major Management Matters / 2024-04-03 Disclosures
  • [Disclosure] SK Square (402340) – Change of CEO (Representative Executive Officer) / 2024-08-14 Semiconductors
  • [Disclosure] Samsung Biologics (207940) – Major Management Matters (Correction) / 2024-06-26 Disclosures
  • [Disclosure] Hana Micron (067310) – Decision on Lawsuit / 2025-07-28 Semiconductors

[Disclosure] Hanwha Aerospace (012450) – Paid-in Capital Increase Decision of Subsidiary / 2025-02-18

Posted on February 18, 2025August 10, 2026 By K-STOCK Editor

Fact Source: Financial Supervisory Service DART

💡 3-Second Summary

Hanwha Aerospace has disclosed that Hanwha Ocean’s overseas subsidiary, Hanwha Ocean USA International LLC, decided on a paid-in capital increase of approximately KRW 153.2B (KRW 29.3B for working capital and KRW 123.9B for acquiring securities in another corporation) without issuing new shares.

📊 [Key Disclosure Contents & Major Financial Figures]

1. Subsidiary Overview

  • Subsidiary Name: Hanwha Ocean USA International LLC (CEO: Yeon-Sung Jang)
  • Primary Business: Maritime Service (Unlisted overseas entity)
  • Total Assets of Subsidiary: KRW 0 (As of year-end 2023)
  • Ratio to Parent Company Consolidated Assets: 0.00% (Based on parent consolidated total assets of KRW 19.54T as of year-end 2023)

2. Key Terms & Financial Figures of Capital Increase

  • Type and Number of New Shares: No new shares issued (-)
  • Par Value and Issue Price per Share: Not applicable (-)
  • Use of Proceeds: Total KRW 153.2B (KRW 153,200,000,000 / Approx. USD 106.3M)
    • Working Capital: KRW 29.3B (KRW 29,300,000,000)
    • Acquisition of Securities in Other Corporations: KRW 123.9B (KRW 123,900,000,000)
  • Payment Date: December 31, 2025 (Final scheduled completion date; capital will be injected in tranches according to project progress)
  • Board Resolution Date: February 18, 2025 (Subsidiary board approval date)

3. Other Details

  • As no new shares are issued, fields for share counts, par value, and issue price are left blank.
  • Amounts were converted using the exchange rate of 1,441.10 KRW/USD as of February 18, 2025; KRW amounts are subject to change based on exchange rates at actual transaction times.
  • The entity is an unlisted foreign entity and is exempt from filing a Securities Registration Statement.

📝 Editor’s Comment (Key Follow-up Checkpoint)

📌 Monitoring Tranche Payments and Capital Allocation Progress

This filing details a capital increase without issuing new shares conducted by an overseas subsidiary to secure working capital and fund securities acquisitions. Tracking the installment payments leading up to the final payment date (December 31, 2025) and observing the actual allocation of funds for working capital and securities acquisition is important for confirming capital injection progress. Detailed status updates can be verified in upcoming periodic reports under ‘Investments in Other Corporations’ and ‘Information on Subsidiaries’.

📢 Disclaimer and Source Notice

Source: This content was newly generated and structured based on official data filed with the Financial Supervisory Service’s Data Analysis, Retrieval and Transfer System (DART).

Investment Risk Warning: This material is provided for informational and language reference purposes only. Under no circumstances does it constitute financial advice or a recommendation to buy or sell specific securities. All investment decisions and financial responsibilities rest entirely with the investor.

Inquiries: For compliance inquiries or copyright-related requests, please contact ksb220805@gmail.com.

Search by
Company Name or Stock Ticker.
Disclosures, Defense

Post navigation

Previous Post: [Disclosure] Hanwha Aerospace (012450) – Paid-in Capital Increase Decision of Subsidiary / 2025-02-18
Next Post: [Disclosure] Samsung Electronics (005930) – Major Business Report (Decision on Treasury Stock Acquisition) / 2025-02-18

Related Posts

  • [Disclosure] Wonik IPS (240810) – Decision on Calling of General Shareholders’ Meeting / 2024-02-21 Semiconductors
  • [Disclosure] Wonik IPS (240810) – Consolidated Financial Results (Provisional) / 2026-02-25 Semiconductors
  • [Disclosure] Celltrion (068270) – Treasury Share Acquisition Decision / 2024-06-14 Disclosures
  • [Disclosure] Celltrion (068270) – CT-P55 (Cosentyx Biosimilar) Korea Marketing Authorization Application / 2026-06-26 Disclosures
  • [Disclosure] ALTEOGEN (196170) – Temporary Postponement of KOSPI Relisting / 2026-07-16 Disclosures
  • [Disclosure] SK Hynix (000660 / SKHY) – Decision on Business Acquisition (Correction) / 2025-03-28 Semiconductors
  • [Disclosure] Hyundai Motor (005380) – Provisional Financial Results / 2026-08-03 Disclosures
  • [Disclosure] Jusung Engineering (036930) – Investor Relations (IR) Presentation / 2024-05-29 Semiconductors
  • [Research] SK hynix (000660 / SKHY) – Kiwoom Securities | 2Q24 Earnings In Line · 3Q24 Consensus Miss Forecast · Marketperform Rating Maintained / 2024-07-26 RESEARCH
  • [Disclosure] Hyundai Motor (005380) – Provisional Sales Results / 2025-12-01 Disclosures
  • [Disclosure] Hana Micron (067310) – Results of Annual General Meeting of Shareholders / 2026-03-26 Semiconductors
  • [Disclosure] Samsung Biologics (207940) – (Correction) Investor Caution Notice on Stock Futures and Options / 2025-08-22 Disclosures
  • [Disclosure] Hanwha Aerospace (012450) – (Correction) Investor Relations (IR) Event / 2024-07-29 Disclosures
  • [Disclosure] SK hynix (000660 / SKHY) – Decision on Acquisition of Shares and Investment Securities of Other Corporation (Correction Report) / 2025-12-03 Disclosures

Copyright © 2026 K-Stock Briefing.

Powered by PressBook News Dark theme